Take our poll: How does Breast Cancer Awareness Month make you feel?
Donate to Breastcancer.org when you checkout at Walgreens in October. Learn more about our Walgreens collaboration.
HER2-Positive Brain Mets Respond to Enhertu
moderators
Posts: 8,558
HER2-Positive Brain Mets Respond to Enhertu
September 12, 2014
The targeted therapy Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) helped control areas of metastatic HER2-positive breast cancer in the brain, according to results from the DESTINY-Breast12 study presented on Sept. 13 at ESMO 2024. Read more…
1
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.